Related Experiment Video
Updated: Aug 14, 2026

Strategies for Assessing Autistic-Like Behaviors in Mice
Published on: September 20, 2024
An update on pharmacologic treatments for autism spectrum disorders
1Children's Hospital and Regional Medical Center, University of Washington, Seattle, WA, USA.
Abstract:
Increasingly recognized over the past 20 years, autism spectrum disorders (ASD) are heterogeneous. Medication treatments remain fundamentally ameliorative, so prioritizing symptoms and matching medications to the patient's constellation of symptoms remains the psychopharmacologic approach to ASD. Atypical antipsychotic medications and glutamatergic agents are receiving increased attention, and antidepressants are being examined for specific symptoms and for younger patients who have autism. Large multisite networks (Research Units on Pediatric Psychopharmacology; Studies to Advance Autism Research and Treatment) have been constructed to expedite studies to elucidate effective treatments for ASD. Findings from these networks are coupled with those from recent independent trials.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Alzheimer's Disease: Treatment
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Psychosis and Antipsychotic Drugs: Overview